Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 1:53 PM ET

Healthcare Equipment and Supplies

Company Overview of ROX Medical, Inc.

Company Overview

ROX Medical, Inc. is a medical device company that develops an interventional vascular therapy for uncontrolled hypertension. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with severe and very severe chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was incorporated in 2003 and is based in San Clemente, California.

150 Calle Iglesia

Suite A

San Clemente, CA 92672

United States

Founded in 2003





Key Executives for ROX Medical, Inc.

Chief Executive Officer and President
Director of Therapy Development, Education and Sales
Director of Quality
Global Vice President of Marketing
Age: 50
Compensation as of Fiscal Year 2015.

ROX Medical, Inc. Key Developments

Rox Medical Completes Enrollment in CONTROL-HTN Trial

ROX Medical announced that it has completed enrollment for CONTROL-HTN trial, an international multi center, prospective, randomized, controlled, blinded endpoint trial of the ROX Coupler for the treatment of arterial hypertension. The CONTROL-HTN trial, NCT01642498, is evaluating the safety and efficacy of a percutaneous procedure creating a fixed connection between a central artery and vein in the upper leg for the treatment of hypertension. The primary outcomes are the safety and efficacy of the ROX Coupler in reduction of ambulatory and office blood pressure at six months post procedure. Paul A. Sobotka, MD, Chief Scientific Officer of ROX Medical, anticipates that last data obtained and results to be presented in the fall of 2014. The company’s flow procedure is a minimally invasive, under one-hour, straight forward, catheter based procedure performed by interventional cardiologists, radiologists and vascular surgeons. It places the ROX Coupler between a central artery and vein in the upper leg creating a fixed volume arterial-venous anastomosis, which immediately reduces blood pressure, and vascular resistance while increasing arterial compliance.

Similar Private Companies By Industry

Company Name Region
CardioInsight Technologies Inc. United States
OptiMedical Inc. United States
Metrex Research Corporation United States
Rex Medical, L.P. United States
Accelerated Orthopedic Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ROX Medical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at